Physician profile
Ellen E Embry
NPI 1245226711
$4,516.06
in general payments reported to CMS, 2019-2025
39 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $499 · 2021: $415 · 2022: $792 · 2023: $1,306 · 2024: $701 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,999 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,999.19 |
| Education | $197.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $622.84 | 2019-2023 | |
| Hologic Sales and Service, LLC | $450.96 | 2019-2025 | Aptima, Acessa Provu System, Coolseal Generator |
| Astellas Pharma US INC | $426.82 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $284.00 | 2023-2024 | Myfembree |
| Shield Therapeutics INC | $269.41 | 2022-2024 | Accrufer |
| Pfizer INC. | $249.54 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $217.87 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $195.39 | 2023-2025 | |
| Agile Therapeutics, INC. | $185.53 | 2021-2024 | Twirla |
| Therapeuticsmd, INC. | $157.00 | 2019-2022 | |
| Myovant Sciences INC. | $150.18 | 2021-2022 | |
| Organon LLC | $144.99 | 2021-2024 | Nexplanon, Nuvaring |
| Allergan, INC. | $119.08 | 2019-2020 | |
| Coopersurgical, INC. | $102.08 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Lilly USA, LLC | $84.49 | 2019-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $81.87 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $72.49 | 2019-2020 | |
| Daiichi Sankyo INC. | $70.43 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $69.64 | 2019-2020 | |
| Exeltis, USA INC. | $55.88 | 2022-2024 | Slynd |
| Exact Sciences Corporation | $46.97 | 2023 | Cologuard Collection Kit |
| Kerecis Limited | $43.39 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Millicent US INC | $42.73 | 2024 | Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $40.46 | 2019-2021 | |
| Gynesonics, INC. | $39.13 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mimedx Group, INC. | $33.37 | 2025 | |
| Lupin INC. | $31.02 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.23 | 2019-2021 | |
| Evofem Biosciences, INC. | $27.96 | 2022 | |
| Scynexis, INC. | $27.39 | 2022 | |
| Mission Pharmacal Company | $24.52 | 2019-2020 | |
| Hologic INC | $17.26 | 2021 | |
| Dysis Medical, INC. | $16.87 | 2020 | |
| Vertical Pharmaceuticals, LLC | $16.60 | 2019 | |
| Boston Scientific Corporation | $15.07 | 2019 | |
| Ironwood Pharmaceuticals, INC | $14.95 | 2020 | |
| Covidien Lp | $14.69 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $13.88 | 2022 | |
| Avion Pharmaceuticals | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Embry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.